News
Florida’s importation program hasn’t brought in a single Canadian drug. It’s not cost-effective and it could be dangerous.
4d
Everyday Health on MSN9 Signs Your Compounded GLP-1 Supplier Is ShadySome online pharmacies sell semaglutide and tirzepatide that are ineffective, unsafe, or an outright scam. Here’s how to find ...
The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...
There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.
Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...
Proponents say direct-to-consumer sales by drugmakers cut out intermediaries that add needlessly to prices. Detractors see ethical issues and prices that are still too high for many patients.
7d
ScienceAlert on MSNOzempic-Like Drugs Could Treat Chronic Migraines, Trial FindsMedications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...
Due to popularity of the medications, GLP-1s were in short supply up until recently. Obesity is a common issue among ...
A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results